Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
May 02, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $16.04
May 02, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $16.01
May 02, 2018
Director
Director Other acquisition or disposition -- --
May 02, 2018
Director
Director Other acquisition or disposition -- --
May 02, 2018
Director
Director Other acquisition or disposition -- --
May 02, 2018
Director
Director Other acquisition or disposition -- --
May 02, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $16.79
Apr 27, 2018
Director
Director Other acquisition or disposition -- --
Apr 27, 2018
Director
Director Other acquisition or disposition -- --
Apr 27, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $15.77
Apr 27, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $16.36
Apr 27, 2018
Director
Director Other acquisition or disposition -- --
Apr 27, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.17
Apr 27, 2018
Director
Director Other acquisition or disposition -- --
Apr 27, 2018
Director
Director Other acquisition or disposition -- --
Apr 27, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.26
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $18.11
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.26

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.